| Model Number |
305C25 |
| Medical Device Problem Codes |
Gradient Increase (1270); Perivalvular Leak (1457); Device Stenosis (4066); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Aortic Valve Stenosis (1717); Valvular Insufficiency/ Regurgitation (4449); Aortic Valve Insufficiency/ Regurgitation (4450); Insufficient Information (4580)
|
| Date of Event |
11/25/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that approximately 15 years post implant of this aortic bioprosthetic valve, a transcatheter valve was implanted valve-in-valve.The reason for intervention was reported as a mean gradient of 38mmhg, mild to moderate aortic regurgitation (ar), moderate paravalvular leak (pvl) and aortic stenosis (as).It was also reported that another manufacturers plug product was used to treat the pvl in accordance with the transcatheter valve.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|